GILEAD SCIENCES, INC.
CIK 882095 · View on SEC EDGAR ↗
- Portfolio value
- $1.6B
- Positions
- 5
- As of
- June 30, 2026
#1,737 of 9,443 by 13F value · top 18.4%
Portfolio value QoQ: -22.1% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 4
- Effective number of positions
- 2.2
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.69% Est. buys $12,962,261 · sells $771,682,600
Median holding: 4.0 quarters Tracked Q4 2024–Q2 2026 · 29.4% still held
- New positions
- 0
- Increased
- 1
- Decreased
- 0
- Closed
- 1
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Sector breakdown
Healthcare
100.0%
Full portfolio 5 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences, Inc. Common Stock | $968,825,351 | 58.76% | 31,424,760 | $290,050,535 | |||
| GLPG Galapagos NV - American Depositary Shares | $500,157,715 | 30.34% | 16,707,477 | $-1,066,595 | |||
| ASMB Assembly Biosciences, Inc. - Common Stock | $136,770,406 | 8.30% | 4,977,089 | $11,745,806 | Up ×1 | ||
| KYTX Kyverna Therapeutics, Inc. - Common Stock | $36,763,720 | 2.23% | 4,126,119 | $1,155,313 | |||
| XLO Xilio Therapeutics, Inc. - Common Stock | $6,230,727 | 0.38% | 650,389 | $760,956 | |||
| No matches | |||||||
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| ACLX | June 30, 2026 | 6,720,803 | $771,682,600 | No longer tracked |
| MRUS | Dec. 31, 2025 | 452,527 | $42,605,417 | No longer tracked |
| TNGX | Dec. 31, 2025 | 4,854,443 | $40,777,321 | 194.3% |
| ALVR | March 31, 2025 | 16,635,286 | $6,986,820 | No longer tracked |
| CYPH | Dec. 31, 2025 | 5,319,148 | $2,414,893 | -25.9% |
| HOOK | Sept. 30, 2025 | 1,875,945 | $2,354,311 | No longer tracked |
| ALLO | Sept. 30, 2025 | 1,156,689 | $1,307,059 | 71.4% |
| KLRS | Sept. 30, 2025 | 317,789 | $848,497 | -29.1% |
| AGEN | March 31, 2025 | 231,663 | $634,757 | 439.7% |
| IKNA | Sept. 30, 2025 | 348,534 | $467,053 | No longer tracked |
| KRON | March 31, 2025 | 188,567 | $179,139 | No longer tracked |
| BRNS | Sept. 30, 2025 | 99,478 | $92,524 | -47.9% |